Verve Therapeutics, Inc. (VERV) Insider Trading -- Recent Executive & Director Transactions

18 insiders reported 54 Form 4 transactions for Verve Therapeutics, Inc. (VERV) over the past 18 months (most recent 2025-07-28). Recent activity: Kathiresan Sekar (Chief Executive Officer) Sell 348,431 shares, GV 2023 GP, L.P. (10% Owner) Sell 6.1M shares, Kathiresan Sekar (Chief Executive Officer) Sell 240,997 shares, Lister Troy (Chief Scientific Officer) Sell 6,952 shares, Nickerson Joan (Chief Administrative Officer) Sell 17,420 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2025-07-28Kathiresan SekarChief Executive OfficerSell348,431$0
2025-07-28GV 2023 GP, L.P.10% OwnerSell6.1M$0
2025-07-28Kathiresan SekarChief Executive OfficerSell240,997$0
2025-07-28Lister TroyChief Scientific OfficerSell6,952$0
2025-07-28Nickerson JoanChief Administrative OfficerSell17,420$0
2025-07-28Dorval AllisonChief Financial OfficerSell13,280$0
2025-07-28Yeshwant KrishnaDirectorSell6.1M$0
2025-07-28Kathiresan SekarChief Executive OfficerSell110,997$0
2025-07-28Yeshwant KrishnaDirectorSell1.8M$0
2025-07-28ADELMAN BURT ADirectorSell428,326$0
2025-07-28Ashe Andrew D.President, Chief Operating Officer and General CounselSell348,828$0
2025-07-28Alphabet Inc.10% OwnerSell6.1M$0
2025-07-28GV 2017 GP, L.L.C.10% OwnerSell6.1M$0
2025-07-28GV 2017 GP, L.P.10% OwnerSell6.1M$0
2025-07-28GV 2017, L.P.10% OwnerSell6.1M$0
2025-07-28GV 2019 GP, L.L.C.10% OwnerSell6.1M$0
2025-07-28GV 2019 GP, L.P.10% OwnerSell6.1M$0
2025-07-28GV 2019, L.P.10% OwnerSell6.1M$0
2025-07-28GV 2023, L.P.10% OwnerSell6.1M$0
2025-07-28GV 2017, L.P.10% OwnerSell4.3M$0
2025-07-28GV 2023 GP, L.L.C.10% OwnerSell6.1M$0
2025-07-28Alphabet Inc.10% OwnerSell4.3M$0
2025-07-28GV 2017 GP, L.L.C.10% OwnerSell4.3M$0
2025-07-28GV 2017 GP, L.P.10% OwnerSell4.3M$0
2025-07-28Yeshwant KrishnaDirectorSell4.3M$0

Source: SEC Form 4 filings · as of 2025-07-28